STOCK TITAN
  1. Home
  2. News
  3. RDHL

Redhill Biopharma Ltd. - RDHL STOCK NEWS

IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill and Kukbo Enter Oral Opaganib License for COVID-19 in South Korea
covid-19
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights Webcast on March 17, 2022
conferences earnings
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Announces Positive Phase 2 Study Results with Oral RHB-107 in Non-Hospitalized COVID-19
clinical trial covid-19
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Announces Record Quarterly Revenues and First Commercial Operations Breakeven
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma's Oral Opaganib Reduces Mortality by 70% Given on Top of Remdesivir and Corticosteroids in Severe COVID-19
covid-19
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma's Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study in Severely Ill Hospitalized COVID-19 Patients
clinical trial covid-19
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia® for the United Arab Emirates
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Announces Additional Insider Buying
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Announces Additional Insider Buying
IMPACT
SENTIMENT
RDHL : Nasdaq
RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori
Stock RDHL logo
Redhill Biopharma Ltd.

Nasdaq:RDHL

RDHL Rankings

#6694 Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

RDHL Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Israel
21 Haarbaa St

About RDHL

redhill biopharma is a biopharmaceutical company focused primarily on development of late clinical-stage new, improved and patented formulations of existing drugs. redhill has an experienced management team, board of directors and advisory board based in israel, the us, canada and europe, with successful track record at big and small pharma of bringing patented drugs to the market, as well as extensive managerial, financial, and transactional expertise